Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA 2023-06-28 09:57
LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma 2023-06-28 04:00
EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST 2023-06-27 19:00
HitGen launches a newly upgraded version of OpenDEL™, a self-service screening kit, to facilitate innovative drug discovery research 2023-06-26 21:30
SK pharmteco doubles viral vector production capacity in Europe 2023-06-23 07:30
Bergen Conference Marks 150 Years Since Discovery of the Leprosy Bacillus 2023-06-22 22:00
I-Mab Announces the Appointment of Raj Kannan as CEO 2023-06-22 20:00
PSYLO ANNOUNCES SPONSORED RESEARCH AGREEMENT WITH DAIICHI SANKYO TO DEVELOP NON-HALLUCINOGENIC PSYCHIATRIC THERAPIES 2023-06-22 19:00
Polyplastics Announces Commercial Availability of DURACON (R) POM PM Series for Medical Industry 2023-06-22 13:00
BioCity Announces Initiation of a Phase 2 Trial for SC0062, a Promising ETA Receptor Antagonist for Chronic Kidney Disease 2023-06-22 08:02
Dr. Yinfei Yin Joins Shanghai ChemPartner as Vice President and Head of Biology and Pharmacology 2023-06-21 23:07
Jadeite Medicines Receives Orphan Drug Designation for Odevixibat in Progressive Familial Intrahepatic Cholestasis (PFIC) from the Ministry of Health, Labour and Welfare of Japan and will also initiate Phase 3 Trial of Odevixibat in PFIC in Japan 2023-06-21 09:00
Clarity commences COMBAT theranostic prostate cancer trial in the US 2023-06-20 21:03
Longbio Pharma Presented Positive Topline Phase 1 Results for LP-003 at ERS2023 2023-06-20 21:00
Minghui Pharmaceutical Inc. Announces First Patient Dosing in Phase 1 Clinical Studies of Both the Antibody-Drug Conjugate Programs Targeting TROP-2 or B7-H3 Respectively, for Treatment of Advanced or Metastatic Solid Tumors 2023-06-20 18:30
Curocell announced encouraging updates on the next-generation anti-CD19 CAR-T, Anbalcabtagene-autoleucel at International Conference on Malignant Lymphoma (ICML) 2023 2023-06-20 08:01
The U.S. FDA Approved the Phase I/II Clinical Trial Application to Evaluate LBL-033, An Anti-MUC16/CD3 Bispecific Antibody Developed by Leads Biolabs, in Advanced Solid Tumors Including Ovarian Cancer 2023-06-16 22:01
Mabwell Announces the U.S. FDA approval of 9MW3811 for IND 2023-06-15 21:00
Mabwell Publishes the Preclinical Study Results on Its Nectin-4 Targeting ADC in A Well-known AACR Journal 2023-06-15 21:00
China Jo-Jo Drugstores Reports Fiscal Year 2023 Financial Results 2023-06-15 21:00
1 45 46 47 48 49 165